Finally, we report that gain-of-function Kv1.2 mutations identified in patients with severe human epilepsy are particularly susceptible to suppression by Slc7a5, and this may underlie the paradoxical observation that both gain- and loss-of-function Kv1.2 mutations lead to severe epilepsy10. This evidence concerns the gene SLC7A5 and epilepsy.